[Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?].
BACKGROUND
Human papillomaviruses (HPV) are the most frequent pathogens of sexually transmitted diseases. They have been associated with an increased incidence of several anogenital tumors. Whether oncogenic HPV are involved in the pathogenesis of prostate cancer has been a subject of great controversy. This study's purpose was to investigate the association between HPV infection and prostate cancer (PCA).


METHODS
The study included 213 consecutive patients with an average age of 65.7 (+/-8.4) years. Within the framework of transrectal, ultrasonic-guided multibiopsy of the prostate, one additional core was examined by means of polymerase chain reaction (PCR) in relation to bacterial, fungal, and viral (including HPV) DNA, with subsequent DNA sequencing. The collected data were correlated with the histological results and with diverse clinical variables. The influence of several predictors for the existence of PCA was verified with a logistic regression model.


RESULTS
No general bacterial DNA (16S rDNA) was detected. Of the 213 patients, 145 (68.1%) showed HPV DNA. In 64% (n=137), high-risk HPV DNA were depicted; these were 18% of the total in each case of HPV genotypes 16 and 18. From our examinations, no significant positive correlation existed between the HPV evidence and the histologically verified PCA that was found in 23.5% of the patients (n=50; odds ratio 1.45; 95% confidence interval 0.71-2.91). The BK virus was not found in any of the cores confirmed through PCR.


CONCLUSIONS
Although no positive correlation between HPV infection and PCA existed in our study, data from the literature suggest an influence of the papillomavirus on PCA oncogenesis. Future studies should highlight to what extent HPV DNA is inserted in the genome of prostate cells and is able to cause subsequent malignant transformation of particular genes.
May
M
M
Urologische Klinik, Carl-Thiem-Klinikum Cottbus, Lehrkrankenhaus der Universitätsklinik Charité zu Berlin, Thiemstrasse 111, 03048 Cottbus, Deutschland. M.May@ctk.de
Kalisch
R
R
Hoschke
B
B
Juretzek
T
T
Wagenlehner
F
F
Brookman-Amissah
S
S
Spivak
I
I
Braun
K-P
KP
Bär
W
W
Helke
C
C
D000368:Aged; D015897:Comorbidity; D004269:DNA, Bacterial / Q000235:genetics* / Q000302:isolation & purification*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000382:microbiology*; D011471:Prostatic Neoplasms / Q000453:epidemiology* / Q000382:microbiology*; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors
D004269:DNA, Bacterial